Scarica l'app Stockscreener
1.00
0.00%
0.00
Dopo l'orario di chiusura:
1.00
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$1.00
Aprire:
$0.995
Volume 24 ore:
39,711
Relative Volume:
0.01
Capitalizzazione di mercato:
$2.26M
Reddito:
$54.43M
Utile/perdita netta:
$-36.70M
Rapporto P/E:
-0.3409
EPS:
-2.9334
Flusso di cassa netto:
$-19.17M
1 W Prestazione:
+0.00%
1M Prestazione:
-3.85%
6M Prestazione:
+27.71%
1 anno Prestazione:
-43.18%
Intervallo 1D:
$0.9426
$1.02
Intervallo di 1 settimana:
$0.9426
$1.10
Portata 52W:
$0.48
$3.44
Trinity Biotech Plc Adr Stock (TRIB) Company Profile
Nome
Trinity Biotech Plc Adr
Settore
Industria
Telefono
-
Indirizzo
-
Confronta TRIB con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TRIB
Trinity Biotech Plc Adr
|
1.00 | 3.73M | 54.43M | -36.70M | -19.17M | -2.9334 |
|
ABT
Abbott Laboratories
|
123.62 | 216.79B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
100.72 | 149.02B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
356.24 | 141.06B | 24.38B | 2.94B | 4.02B | 7.6145 |
|
MDT
Medtronic Plc
|
90.70 | 116.68B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
82.45 | 49.01B | 5.88B | 1.34B | 577.90M | 2.3455 |
Trinity Biotech Plc Adr Stock (TRIB) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2015-10-23 | Downgrade | Craig Hallum | Buy → Hold |
| 2015-09-03 | Iniziato | Raymond James | Outperform |
| 2015-07-29 | Reiterato | ROTH Capital | Buy |
| 2008-07-22 | Reiterato | Roth Capital | Buy |
| 2008-03-17 | Reiterato | Roth Capital | Buy |
| 2007-12-10 | Reiterato | Roth Capital | Buy |
| 2007-10-26 | Reiterato | Roth Capital | Buy |
Mostra tutto
Trinity Biotech Plc Adr Borsa (TRIB) Ultime notizie
Operating cash flow per share of Trinity Biotech Plc Sponsored ADR Class A – LS:A404JF - TradingView
EBIT per share of Trinity Biotech plc ADR – MUN:TRB0 - TradingView
Trinity Biotech : 2025 AGM Notice Sent to holders of Ordinary Shares - MarketScreener
TRINITY B ADR : Trinity Biotech plc to Present at Sidoti & Company's Micro-Cap Conference on January 10, 2011 - MarketScreener
Upcoming Stock Splits This Week (August 25 to August 29) – Stay Invested - TipRanks
Trinity Biotech plc Appoints Paul Tivnan as Non-Executive Director - MarketScreener
Trinity Biotech appoints Paul Tivnan to board of directors - Investing.com
Trinity Biotech receives approval for offshore manufacturing of HIV test - Investing.com
TRIB’s Market Quandary: Decoding the Ups and Downs of 2025 - investchronicle.com
Trinity Biotech stock soars after NY regulatory approval for preeclampsia test By Investing.com - Investing.com South Africa
Trinity Biotech stock soars after NY regulatory approval for preeclampsia test - Investing.com India
Trinity Biotech receives NY approval for preeclampsia test - Investing.com
Trinity Biotech Receives Regulatory Approval to Begin FDA-Cleared PreClara™ Preeclampsia Testing Service - GlobeNewswire Inc.
Trinity Biotech stock rises on successful CGM calibration-free trial By Investing.com - Investing.com South Africa
Trinity Biotech stock rises on successful CGM calibration-free trial - Investing.com India
Trinity Biotech reports positive results for calibration-free CGM By Investing.com - Investing.com South Africa
Trinity Biotech reports positive results for calibration-free CGM - Investing.com India
Trinity Biotech (TRIB) to Release Earnings on Wednesday - Defense World
Trinity Biotech launches preeclampsia testing service for maternal health By Investing.com - Investing.com South Africa
Trinity Biotech launches preeclampsia testing service for maternal health - Investing.com India
Trinity Biotech Plc Sponsored ADR Class A to Host Earnings Call - ACCESS Newswire
Cadence Bank (CADE) Stock: A Year of Market Fluctuations - investchronicle.com
Trinity Biotech Unveils CGM+: An AI-Native Platform Targeting the $260 Billion AI Wearable Market - Sahm
Trinity Biotech Reaches Profitability Inflection Point, Marking Major Milestone in Strategic Turnaround - MarketScreener
Trinity Biotech Secures Key Regulatory Approval for Offshored and Outsourced Manufacturing of Its Flagship Rapid HIV Test, Accelerating Strategic and Financial Performance Transformation - MarketScreener
Trinity Biotech receives WHO approval for offshore HIV test manufacturing - Investing.com
Trinity Biotech Appoints New Interim CFO - Investing.com
Trinity Biotech Further Strengthens Focus on Continuous Glucose Monitoring – Appoints Barclays to Advise on Ongoing Strategic Realignment Process - MarketScreener
Trinity Biotech stock hits 52-week low at $0.72 amid challenges - Investing.com
Trinity Biotech Reports Landmark First-Day Accuracy Gains in CGM Pre-Pivotal Trial - MarketScreener
Trinity Biotech secures US funding for HIV tests - Investing.com
Trinity Biotech faces US aid policy impact, PPP loan scrutiny - Investing.com
Trinity Biotech announces breakthrough in CGM technology - Investing.com
Trinity Biotech Expands Market Reach with New ADS Offering - Nasdaq
Trinity Biotech Announces Amended Credit Agreement with Perceptive to Enhance Liquidity and Drive Transformation Plan - MarketScreener
Trinity Biotech plc Receives Early Approval from the World Health Organization to Begin Offshore Manufacturing of TrinScreen HIV & Uni-Gold HIV - MarketScreener
Trinity Biotech : Regains Compliance with Nasdaq Listing Requirements Form 6 K - MarketScreener
Trinity Biotech Announces Strategic Investment in Novus Diagnostics to Advance Rapid Sepsis Testing Platform - MarketScreener
Saudi Arabia Lyme Disease Testing Market Size & Outlook, 2030 - Grand View Research
Trinity Biotech Announces Positive Pre-Pivotal Trial Results for Its Next-Generation Continuous Glucose Monitor Technology - MarketScreener
Trinity Biotech Announces Acquisition of Metabolomics Diagnostics to Grow Presence in Maternal Health Market - MarketScreener
Trinity Biotech to Initiate CGM Market Study in India in Furtherance of Intended Collaboration with Bayer - MarketScreener
Trinity Biotech Provides an Update on the Continued Development of Its Continuous Glucose Monitor Technology - MarketScreener
Trinity Biotech plc Appoints Global Life Sciences Leader Adrian Donohue as Chief Commercial Officer - MarketScreener
Trinity Biotech appoints new biosensor marketing director - Investing.com
Trinity Biotech plc Announces Chief Financial Officer Changes - MarketScreener
Trinity Biotech Attending 84th Scientific Sessions of the American Diabetes Association - MarketScreener
Trinity Biotech Announces the Appointment of Avinash Kale as Continuous Glucose Monitor Programme Director to Advance Innovation and Development - MarketScreener
symbol__ Stock Quote Price and Forecast - CNN
Trinity Biotech plc Share Price ADR Each Representing 20 Ord Shares SPON - Hargreaves Lansdown
Trinity Biotech announces ADS ratio change - Investing.com
Trinity Biotech Plc Adr Azioni (TRIB) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.34%
14.63%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):